Veteran investor and operator focused on growth-stage technology and healthcare companies, known for board-level strategic and capital markets advisory. David W. Lewis brings experience in corporate finance, M&A and operational scaling from prior roles in private equity and senior corporate development. He is active in governance, fundraising and exit planning, partnering with management teams to drive revenue expansion and prepare businesses for strategic sale or IPO.
Veteran investor and operator focused on growth-stage technology and healthcare companies, known for board-level strategic and capital markets advisory. David W. Lewis brings experience in corporate finance, M&A and operational scaling from prior roles in private equity and senior corporate development. He is active in governance, fundraising and exit planning, partnering with management teams to drive revenue expansion and prepare businesses for strategic sale or IPO.
Focuses on growth-stage technology and healthcare companies, emphasizing board-level partnership to accelerate revenue, tighten unit economics and prepare for strategic exits. Combines corporate finance and M&A rigor with operational scaling playbooks to size capital raises, sequence milestones and optimize governance. Allocates capital selectively to companies with repeatable SaaS or healthcare commercialization models, privileging measurable KPIs, clear exit pathways and staged capital deployment tied to operational deltas and valuation inflection points.
Focuses on growth-stage technology and healthcare companies, emphasizing board-level partnership to accelerate revenue, tighten unit economics and prepare for strategic exits. Combines corporate finance and M&A rigor with operational scaling playbooks to size capital raises, sequence milestones and optimize governance. Allocates capital selectively to companies with repeatable SaaS or healthcare commercialization models, privileging measurable KPIs, clear exit pathways and staged capital deployment tied to operational deltas and valuation inflection points.
| Trades 1561 | Longs Won 1045/1561 66% | Profit Factor 6.59 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $391,705.75 |
| Average Win $95,528.22 | Best Trade (Sep 08) $12.88M | Sharpe Ratio -13.15 |
| Average Loss -$29,354.6 | Worst Trade (Aug 02) -$1.06M | Z-Score 10.56 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1m 4w | Expectancy $54,247.29 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 9,901 | 8,911 | 7,921 | 6,931 | 5,941 | 4,950 | 3,960 | 2,970 | 1,980 | 990 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 55,429 | $11.15M | $17.12M | - | $5.97M | 53.57% | -7.354% |
AB AllianceBernstein Holding L.P. | 6,800 | $254,596 | $249,968 | - | -$4,628 | -1.82% | +0.109% |
ABBV AbbVie Inc. | 16,195 | $2.94M | $4.06M | - | $1.12M | 38.27% | -2.513% |
ABT Abbott Laboratories | 18,343 | $2.36M | $1.94M | - | -$416,752.16 | -17.69% | +0.085% |
ADP Automatic Data Processing Inc. | 3,565 | $1.07M | $949,929.86 | - | -$118,196.75 | -11.07% | +0.982% |
AFL Aflac Inc. | 3,972 | $358,599.25 | $506,350.56 | - | $147,751.31 | 41.2% | +0.094% |
AGG iShares Core U.S. Aggregate Bond ETF | 3,970 | $394,036.32 | $386,558.9 | - | -$7,477.42 | -1.9% | -0.256% |
AMAT Applied Materials, Inc. | 2,500 | $431,360.94 | $1.27M | - | $837,814.08 | 194.23% | +1.176% |
AMD Advanced Micro Devices, Inc. | 8,237 | $1.05M | $3.92M | - | $2.87M | 272.31% | -1.904% |
AMGN Amgen Inc. | 3,649 | $1.08M | $1.41M | - | $323,462.6 | 29.9% | -0.64% |
AMT American Tower Corporation | 2,051 | $408,382.81 | $355,561.36 | - | -$52,821.45 | -12.93% | -0.631% |
AMZN Amazon.com Inc | 38,160 | $6.91M | $10.36M | - | $3.45M | 49.92% | +15.321% |
AOHY Angel Oak High Yield Opportunities ETF | 27,646 | $302,284.02 | $303,000.16 | - | $716.14 | 0.24% | -0.535% |
APD Air Products and Chemicals, Inc. | 862 | $237,440.84 | $254,195.19 | - | $16,754.35 | 7.06% | -1.769% |
APH Amphenol Corporation | 18,544 | $445,344.98 | $745,005.2 | - | $299,660.22 | 67.29% | +0.551% |
ARCC Ares Capital Corporation | 50,248 | $989,253.09 | $942,652.48 | - | -$46,600.61 | -4.71% | -0.372% |
AVB AvalonBay Communities, Inc. | 1,955 | $394,434.04 | $362,867.55 | - | -$31,566.49 | -8% | -1.156% |
AVGO Broadcom Inc. | 14,242 | $2.38M | $5.54M | - | $3.17M | 133.04% | +0.371% |
AXP American Express Company | 4,020 | $1.02M | $1.35M | - | $328,574.16 | 32.11% | -0.376% |
BAC Bank of America Corporation | 12,616 | $550,004.65 | $781,561.2 | - | $231,556.55 | 42.1% | +0.356% |